Cooley LLP

Life Sciences Department

Current View:

This content is provided by Chambers. Learn more about our methodology

What the team is known for Much-admired practice with a deep bench of transactional attorneys and a strong Bay Area presence. Recommended for its representation of biotechnology companies in corporate and commercial matters including high-value M&A, venture capital investments and licensing and collaboration agreements. Offers substantial expertise in relation to medical device patent prosecution matters.

Strengths One commentator describes the team as "the best representation for biotech companies, given their depth of experience," and notes: "The team is execution focused and cognizant of providing excellent counsel without over-lawyering."

"Cooley stands out as having amazing breadth," a further interviewee notes, adding: "The lawyers' level of detail is amazing, they're responsive and they work hard."

Work highlights Represented immunotherapy developer Harpoon Therapeutics in a $75.6 million initial public offering, comprising 5,400,000 shares of common stock.

Notable practitioners

Fred Muto
's clients include emerging and established companies, investment banks and venture capital investors in the healthcare, medical device and biotechnology sectors. His work spans an array of transaction types, from public offerings and private placements to strategic collaborations.

Kay Chandler
maintains a broad transactional life sciences practice advising major clients on matters including acquisitions, manufacturing agreements and licensing.

Laura Berezin
comes recommended as "very down to earth and always available" by one client, who adds: "She provides good guidance." She frequently works with a range of financial institutions and private and public businesses who are active in the life sciences industry.

Peers describe
Lila Hope
as "practical and energetic." She is well equipped to take on a range of transactional matters for life sciences businesses of all sizes, including those involved in medical devices, pharmaceuticals and digital health facilities.

One client describes
Mark Weeks
as "a tremendous resource for our company." He is adept at representing and advising emerging life sciences companies throughout their growth, from pre-incorporation to M&A.

Marya Postner
"has a towering intellect and memory for detail, and is incredibly detail-oriented," clients note. She maintains a respected transactional practice counseling life sciences companies in a broad range of matters.

Mika Mayer
is "a smart and tough lawyer with a lot of great clients," sources report. She centers her practice on patent prosecution and portfolio management advice for life sciences companies and has experience of representation in patent litigation, post-grant reviews and due diligence.

Robert Jones
is "calm, measured, thoughtful and smart," according to peers. He advises life sciences and biotechnology businesses on a wide range of corporate matters, including financings, licensing and partnership transactions.